Global Total Pharmaceutical Sales by Country

Analysis of the Global Total Pharmaceutical Sales by Country reveals that Germany led in sales with $65.17 billion, followed by South Korea at $30.85 billion. The United Kingdom and Italy followed closely with $28.95 billion and $26.59 billion, respectively. Smaller markets included Australia, Belgium, Switzerland, Sweden, Denmark, Norway, Estonia, and Luxembourg with varying sales from $13.95 billion down to $0.2751 billion.

Year-on-year variations indicate a general upward trend. For instance, Germany and Australia experienced significant growth rates of 4.52% and 4.61%, respectively, in 2023. The UK and Italy's growth rates were modest, at 1.2% and 0.14%, respectively. Other notable variations included Belgium at 4.24%, Switzerland at 3.66%, and Luxembourg at 3.24%. Smaller markets such as Estonia and Norway also saw positive shifts, with 4.54% and 2.67% increases, respectively.

Future trends to monitor in the Global Total Pharmaceutical Sales by Country include emerging market potentials, regulatory changes, and advancements in pharmaceutical technology. Given the ongoing investments in healthcare and drug development, higher growth rates might be expected in markets with smaller current values but significant future potential, such as Belgium and Australia.

Top countries in Total Pharmaceutical Sales by Country

# 10 Countries Million US Dollars Last Year YoY 5-years CAGR
1 1 Germany 65,170 2023 +1.68% +4.52% View data
2 2 South Korea 30,850 2023 +3.61% +3.27% View data
3 3 United Kingdom 28,950 2023 +1.43% +1.2% View data
4 4 Italy 26,590 2023 +1.82% +0.14% View data
5 5 Australia 13,950 2023 +2.83% +4.61% View data
6 6 Belgium 9,710 2023 +2.4% +4.24% View data
7 7 Switzerland 8,080 2023 +1.61% +3.66% View data
8 8 Sweden 5,970 2023 +4.45% +1.63% View data
9 9 Denmark 4,260 2023 +2.35% +2.43% View data
10 10 Norway 3,860 2023 +2.99% +2.67% View data

Top Countries about Pharmacy